Cargando…
Endothelial Dysfunction in Pregnancy Complications
The endothelium, which constitutes the inner layer of blood vessels and lymphatic structures, plays an important role in various physiological functions. Alterations in structure, integrity and function of the endothelial layer during pregnancy have been associated with numerous gestational complica...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698592/ https://www.ncbi.nlm.nih.gov/pubmed/34944571 http://dx.doi.org/10.3390/biomedicines9121756 |
_version_ | 1784620313975193600 |
---|---|
author | Kornacki, Jakub Gutaj, Paweł Kalantarova, Anastasia Sibiak, Rafał Jankowski, Maurycy Wender-Ozegowska, Ewa |
author_facet | Kornacki, Jakub Gutaj, Paweł Kalantarova, Anastasia Sibiak, Rafał Jankowski, Maurycy Wender-Ozegowska, Ewa |
author_sort | Kornacki, Jakub |
collection | PubMed |
description | The endothelium, which constitutes the inner layer of blood vessels and lymphatic structures, plays an important role in various physiological functions. Alterations in structure, integrity and function of the endothelial layer during pregnancy have been associated with numerous gestational complications, including clinically significant disorders, such as preeclampsia, fetal growth restriction, and diabetes. While numerous experimental studies have focused on establishing the role of endothelial dysfunction in pathophysiology of these gestational complications, their mechanisms remain unknown. Numerous biomarkers of endothelial dysfunction have been proposed, together with the mechanisms by which they relate to individual gestational complications. However, more studies are required to determine clinically relevant markers specific to a gestational complication of interest, as currently most of them present a significant overlap. Although the independent diagnostic value of such markers remains to be insufficient for implementation in standard clinical practice at the moment, inclusion of certain markers in predictive multifactorial models can improve their prognostic value. The future of the research in this field lies in the fine tuning of the clinical markers to be used, as well as identifying possible therapeutic techniques to prevent or reverse endothelial damage. |
format | Online Article Text |
id | pubmed-8698592 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86985922021-12-24 Endothelial Dysfunction in Pregnancy Complications Kornacki, Jakub Gutaj, Paweł Kalantarova, Anastasia Sibiak, Rafał Jankowski, Maurycy Wender-Ozegowska, Ewa Biomedicines Review The endothelium, which constitutes the inner layer of blood vessels and lymphatic structures, plays an important role in various physiological functions. Alterations in structure, integrity and function of the endothelial layer during pregnancy have been associated with numerous gestational complications, including clinically significant disorders, such as preeclampsia, fetal growth restriction, and diabetes. While numerous experimental studies have focused on establishing the role of endothelial dysfunction in pathophysiology of these gestational complications, their mechanisms remain unknown. Numerous biomarkers of endothelial dysfunction have been proposed, together with the mechanisms by which they relate to individual gestational complications. However, more studies are required to determine clinically relevant markers specific to a gestational complication of interest, as currently most of them present a significant overlap. Although the independent diagnostic value of such markers remains to be insufficient for implementation in standard clinical practice at the moment, inclusion of certain markers in predictive multifactorial models can improve their prognostic value. The future of the research in this field lies in the fine tuning of the clinical markers to be used, as well as identifying possible therapeutic techniques to prevent or reverse endothelial damage. MDPI 2021-11-24 /pmc/articles/PMC8698592/ /pubmed/34944571 http://dx.doi.org/10.3390/biomedicines9121756 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Kornacki, Jakub Gutaj, Paweł Kalantarova, Anastasia Sibiak, Rafał Jankowski, Maurycy Wender-Ozegowska, Ewa Endothelial Dysfunction in Pregnancy Complications |
title | Endothelial Dysfunction in Pregnancy Complications |
title_full | Endothelial Dysfunction in Pregnancy Complications |
title_fullStr | Endothelial Dysfunction in Pregnancy Complications |
title_full_unstemmed | Endothelial Dysfunction in Pregnancy Complications |
title_short | Endothelial Dysfunction in Pregnancy Complications |
title_sort | endothelial dysfunction in pregnancy complications |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698592/ https://www.ncbi.nlm.nih.gov/pubmed/34944571 http://dx.doi.org/10.3390/biomedicines9121756 |
work_keys_str_mv | AT kornackijakub endothelialdysfunctioninpregnancycomplications AT gutajpaweł endothelialdysfunctioninpregnancycomplications AT kalantarovaanastasia endothelialdysfunctioninpregnancycomplications AT sibiakrafał endothelialdysfunctioninpregnancycomplications AT jankowskimaurycy endothelialdysfunctioninpregnancycomplications AT wenderozegowskaewa endothelialdysfunctioninpregnancycomplications |